EQS-AFR: Marinomed Biotech AG: Release of a Financial report


Werte in diesem Artikel
Aktien

8.40 EUR -0.15 EUR -1.75 %

EQS Dissemination of Financial Reports: Marinomed Biotech AG / Release of Financial Reports
Marinomed Biotech AG: Release of a Financial report

27.02.2025 / 12:53 CET/CEST
Announcement according to Article 125 BörseG transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Werbung


Marinomed Biotech AG hereby announces that the Financial report (half-year) is immediately available under the following internet address:

Report Type: Financial report (half-year) according to § 125 BörseG

Language: German
Address: https://www.marinomed.com/de/investoren-esg/finanzpublikationen

Language: English
Address: https://www.marinomed.com/en/investors-esg/financial-publications


27.02.2025 CET/CEST


Language: English
Company: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Internet: www.marinomed.com

 
End of News EQS News Service

2092783  27.02.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2092783&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Aktuelle Marinomed Biotech Aktie News

Werbung

Marinomed Biotech Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Marinomed Biotech nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
28.10.25 Marinomed Biotech Kaufen GBC
12.06.25 Marinomed Biotech Kaufen GBC
04.04.25 Marinomed Biotech Kaufen GBC